home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Exploring The Impact Of The HPV Vaccine

  September, 27 2006 10:32
your information resource in human molecular genetics
Global vaccination of women with the recently approved, but controversial, cervical cancer vaccine is predicted to prevent 70-80% of these cancers. As T.-C. Wu and Richard Roden discuss in Nature Reviews Cancer (Vol. 6, issue 10), the most effective strategies would involve the mandatory vaccination of girls before they reach sexual maturity and global distribution of the vaccine.

Cervical cancer is currently the second leading cause of cancer deaths in women worldwide. Almost all cases of cervical cancer are caused by the sexually transmitted human papillomavirus (HPV), and a vaccine that prevents infection with HPV has recently been licensed in the United States and Australia and has been recommended for approval by the European Medicines Agency. However, opinions about how and when the vaccine should be administered have been controversial.

For example, at what age should girls be vaccinated, and should HPV vaccination be mandatory? The authors provide evidence that it is best to widely administer the vaccine before girls initiate sexual activity, but early mandatory vaccination has encountered resistance, especially from conservative religious groups in the United States. However, the authors argue that because fears of HIV infection are so widespread, HPV vaccination is not likely to promote risky sexual behaviour.

Author contact:

T.-C. Wu (Departments of Pathology, Oncology, Obstetrics and Gynecology, and Molecular Microbiology and Immunology, The Johns Hopkins University, Baltimore, MD, USA)
E-mail: wutc@jhmi.edu

Richard Roden (Departments of Pathology, Oncology, and Obstetrics and Gynecology, The Johns Hopkins University, Baltimore, MD, USA)
E-mail: roden@jhmi.edu

Editorial contact:
Sarah Seton-Rogers (Associate Editor, Nature Reviews Cancer)
E-mail: s.seton-rogers@nature.com

(C) Nature Reviews Cancer press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.